SurgiMend Mesh at the Hiatus
Hiatal Hernia Repair Using Surgimend Mesh: A Pilot Study
1 other identifier
interventional
9
1 country
1
Brief Summary
Prospective, single-arm, open-label study to evaluate re-occurrence and quality of life in subjects undergoing primary Hiatal hernia repair using SurgiMend biological mesh. Up to 15, with a target of 10, subjects are planned to be enrolled at one site. All subjects will receive the SurgiMend mesh during surgery. Data collected will be compared to historical data. Subjects will complete a pre-operative visit. After surgery, in addition to any standard of care visits, subjects will complete 3- and 6-month follow-ups involving a phone QOL survey and will have an upper GI series at 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2020
CompletedFirst Posted
Study publicly available on registry
February 25, 2020
CompletedStudy Start
First participant enrolled
March 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2023
CompletedResults Posted
Study results publicly available
April 8, 2026
CompletedApril 8, 2026
November 1, 2024
3.4 years
February 21, 2020
November 20, 2024
March 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Recurrence Rate
Recurrence rate will be analyzed by a Upper gastrointestinal tract radiography (UGI) and clinical evaluation in conjunction with patient's reported physiological assessment per the GERD-HRQL.
6 months post surgery
Secondary Outcomes (1)
Quality of Life Using GERD-HRQL Scale
6 month post surgery
Study Arms (1)
SurgiMend Mesh
OTHERSurgiMend Mesh - FDA approved noncross-linked bovine dermis biologic mesh. SurgiMend Mesh will be used according to FDA approved recommendations for the use of abdominal wall hernia reinforcement. SurgiMend is intended for implantation to reinforce soft tissue where weakness exists and for surgical repair of damaged or ruptured soft tissue membranes. SurgiMend is specifically indicated for: Hernia repair including abdominal, inguinal, femoral, diaphragmatic, scrotal, umbilical, and incisional hernias.
Interventions
Following placement of SurgiMend mesh during laparoscopic hiatal hernia repair, patient will be scheduled for follow up using an upper GI series to check for recurrence of the hiatal hernia. Follow up upper GIs will be performed at 6 months post-surgery. Subjects will also complete a QOL survey to assess other GI associated symptoms before and after surgical repair. The QOL survey can be administered by phone by study team members
Eligibility Criteria
You may qualify if:
- Diagnosis of type 3 or 4 hiatal hernia (8)
- Subject is able to give informed consent
- Adults at least 18 years of age
You may not qualify if:
- Currently pregnant
- Prior hiatal hernia repair
- Prior gastric surgery
- Prior foregut surgery
- Known esophageal dysfunction or dysmotility
- Cirrhosis or ascites
- Known malignancy
- Known allergy to biologic mesh
- Known allergy to barium or other contrast material used in UGI
- Religious objection to animal implant
- Cognitive impairment
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kettering Health Networklead
- Integra LifeSciences Corporationcollaborator
Study Sites (1)
Kettering Health Network - Grandview Medical Center
Dayton, Ohio, 45405, United States
Related Publications (8)
Furnee E, Hazebroek E. Mesh in laparoscopic large hiatal hernia repair: a systematic review of the literature. Surg Endosc. 2013 Nov;27(11):3998-4008. doi: 10.1007/s00464-013-3036-y. Epub 2013 Jun 21.
PMID: 23793804BACKGROUNDLidor AO, Steele KE, Stem M, Fleming RM, Schweitzer MA, Marohn MR. Long-term quality of life and risk factors for recurrence after laparoscopic repair of paraesophageal hernia. JAMA Surg. 2015 May;150(5):424-31. doi: 10.1001/jamasurg.2015.25.
PMID: 25785415BACKGROUNDNason KS, Luketich JD, Qureshi I, Keeley S, Trainor S, Awais O, Shende M, Landreneau RJ, Jobe BA, Pennathur A. Laparoscopic repair of giant paraesophageal hernia results in long-term patient satisfaction and a durable repair. J Gastrointest Surg. 2008 Dec;12(12):2066-75; discussion 2075-7. doi: 10.1007/s11605-008-0712-7. Epub 2008 Oct 8.
PMID: 18841422BACKGROUNDAdelman DM, Selber JC, Butler CE. Bovine versus Porcine Acellular Dermal Matrix: A Comparison of Mechanical Properties. Plast Reconstr Surg Glob Open. 2014 Jun 6;2(5):e155. doi: 10.1097/GOX.0000000000000072. eCollection 2014 May.
PMID: 25289348BACKGROUNDVelanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007;20(2):130-4. doi: 10.1111/j.1442-2050.2007.00658.x.
PMID: 17439596BACKGROUNDRadiologic Society of North America (2019). Radiation dose in X-Ray and CT Exam. Available at https://www.radiologyinfo.org/en/info.cfm?pg=safety-xray
BACKGROUNDK. S. Silvipriya, K. Krishna Kumar*, A. R. Bhat, B. Dinesh Kumar, Anish John, Panayappan Lakshmanan. Collagen: Animal Sources and Biomedical Application. Journal of Applied Pharmaceutical Science Vol. 5 (03), pp. 123-127, March, 2015. DOI: 10.7324/JAPS.2015.50322
BACKGROUNDKahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol. 2008;22(4):601-16. doi: 10.1016/j.bpg.2007.12.007.
PMID: 18656819BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Paul Levy
- Organization
- Kettering Health
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Levy, DO
Kettering Health Network
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2020
First Posted
February 25, 2020
Study Start
March 31, 2020
Primary Completion
August 16, 2023
Study Completion
September 5, 2023
Last Updated
April 8, 2026
Results First Posted
April 8, 2026
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share